Acadian Asset Management
DCOY

Acadian Asset Management’s Decoy Therapeutics DCOY Stock Holding History

Acadian Asset Management’s Portfolio DCOY Stock Details DCOY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-1
Closed -$23K – 1987
2021
Q2 		$23K Buy
+1
New +$44.5K ﹤0.01% 1927
2020
Q2 		– Hold
0
– -$6K – 2327
2020
Q1 		– Hold
0
– – – 1733
2019
Q4 		– Hold
0
– – – 1667
2019
Q3 		– Hold
0
– – – 1495
2019
Q2 		– Hold
0
– -$144K – 2021
2019
Q1 		– Hold
0
– – – 1434
2018
Q3 		– Hold
0
– -$32K – 1780
2018
Q2 		– Hold
0
– – – 1477
2016
Q3 		– Hold
0
– -$114K – 1537
2016
Q2 		– Hold
0
– – – 1013

Other funds holding DCOY

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SCM
Sio Capital Management New York $604M AUM 96.57% 1-Year Est. Return
MS
Maven Securities St Helier, Jersey $5.06B AUM 59.27% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
KC
Kepos Capital New York $73.4M AUM 4.78% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return
XSC
X-Square Capital Guaynabo, Puerto Rico $394M AUM 44.75% 1-Year Est. Return

Acadian Asset Management's DCOY Position: Q3 2021 in Review

Acadian Asset Management sold out of Decoy Therapeutics (DCOY) in Q3 2021, closing a stake of 1 share — an estimated $23K sold.

Acadian Asset Management first reported a position in DCOY in Q2 2021 and held it in 1 quarter. The position peaked at $23K in Q2 2021. 20 funds tracked by Wall St. Rank hold DCOY as of Q3 2021.

  • Acadian Asset Management reported no remaining Decoy Therapeutics position as of Q3 2021 after selling out during the quarter.
  • Acadian Asset Management sold 1 Decoy Therapeutics share in Q3 2021, an estimated $23K.
  • Acadian Asset Management first reported a position in Decoy Therapeutics in Q2 2021 and held it in 1 quarter.
  • Acadian Asset Management's Decoy Therapeutics position peaked at $23K in Q2 2021.
  • 20 funds tracked by Wall St. Rank held Decoy Therapeutics as of Q3 2021.

Based on Acadian Asset Management's 13F filing for Q3 2021, filed 12 Nov 2021.